Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 541760, 3 pages
http://dx.doi.org/10.1155/2012/541760
Research Article

Association of HLA-DQB1*05:02 and DRB1*16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis

1Laboratory of Immunogenetics, IME Foundation at Tor Vergata Polyclinic Hospital, 00133 Rome, Italy
2Department of Neurosciences, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy
3Department of Thoracic Surgery, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy
4Department of Neurosciences, IRCCS Fondazione S. Lucia, 00179 Rome, Italy

Received 16 May 2012; Revised 31 July 2012; Accepted 15 September 2012

Academic Editor: I. R. Mackay

Copyright © 2012 Manuela Testi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. E. Somnier, “Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis,” Neurology, vol. 65, no. 6, pp. 928–930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Casetta, E. Groppo, R. De Gennaro et al., “Myasthenia gravis: a changing pattern of incidence,” Journal of Neurology, vol. 257, no. 12, pp. 2015–2019, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Pallaver, A. P. Riviera, S. Piffer et al., “Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years,” Neuroepidemiology, vol. 36, no. 4, pp. 282–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Pirskanen, “Genetic associations between myasthenia gravis and the HL A system,” Journal of Neurology Neurosurgery and Psychiatry, vol. 39, no. 1, pp. 23–33, 1976. View at Google Scholar · View at Scopus
  5. F. Baggi, C. Antozzi, F. Andreetta et al., “Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population,” Annals of the New York Academy of Sciences, vol. 841, pp. 355–359, 1998. View at Google Scholar · View at Scopus
  6. C. Vandiedonck, M. Giraud, and H. J. Garchon, “Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex,” Journal of Autoimmunity, vol. 25, pp. 6–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Saruhan-Direskeneli, A. Kiliç, Y. Parman, P. Serdaroǧlu, and F. Deymeer, “HLA-DQ polymorphism in Turkish patients with myasthenia gravis,” Human Immunology, vol. 67, no. 4-5, pp. 352–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. H. Niks, J. B. M. Kuks, B. O. Roep et al., “Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5,” Neurology, vol. 66, no. 11, pp. 1772–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Bartoccioni, F. Scuderi, A. Augugliaro et al., “HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5,” Neurology, vol. 72, no. 2, pp. 195–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. AAEM Quality Assurance Committee, “Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement,” Muscle and Nerve, vol. 24, no. 9, pp. 1236–1238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Lavrnic, A. Nikolic, M. De Baets et al., “Familial occurrence of autoimmune myasthenia gravis with different antibody specificity,” Neurology, vol. 70, no. 21, pp. 2011–2013, 2008. View at Publisher · View at Google Scholar · View at Scopus